Observational study to predict readmission for heart failure patients

Not Applicable

Completed

• Conditions: Topic: Cardiovascular; Subtopic: Cardiovascular (all Subtopics); Disease: Cardiovascular; Circulatory System; Heart failure

• Registration Number: ISRCTN96643197
• Lead Sponsor: Hull and East Yorkshire Hospitals NHS Trust

Brief Summary

2018 results in https://www.ncbi.nlm.nih.gov/pubmed/29314447 2021 results in https://pubmed.ncbi.nlm.nih.gov/33754159/ (added 24/03/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-04-18
• Study Completion: 2017-12-31
• Last Update Posted: 12 April 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1145

Inclusion Criteria

Inclusion Criteria for the Risk Stratification Component:
1. Age >18 years
2. In hospital
3. Usual residence is in the catchment region for Hull & East Yorkshire Hospitals Trust (this enables efficient follow-up)
4. Either
4.1. Treated with loop diuretics Or
4.2.Clinical diagnosis of heart failure
5. Willing and able to provide informed consent

Additional Inclusion Criteria for the Monitoring Component of the Study:
Heart failure as a dominant diagnosis meaning that
1. There is objective evidence of cardiac dysfunction as evidenced by a least ONE of the following:
1.1. Left ventricular ejection fraction <= 40%
1.2. Left atrial dimension >4.0 cm (or >2.5 cm/m in height)
1.3. NT ? ProBNP > 400pg/ml (>47.3pmol/L (or BNP >150 pg/ml) if in sinus rhythm or >1,200pg/ml (or BNP >450pg/ml) if in atrial fibrillation
2. The patient is receiving loop diuretics
3. Target Gender: Male & Female ; Lower Age Limit 80 years

Exclusion Criteria

Unable to understand and comply with protocol or to give informed consent. There are no other exclusion criteria for the risk stratification study.

Additional Exclusion Criteria for the Monitoring Component of the Study:
The duration of admission is likely to be determined by the need for treatment other than for heart failure (for instance, patients with infective endocarditis, major stroke disability or major cognitive impairment will be excluded).

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of patients with an ?optimal length of stay?; Timepoint(s): Discharge.

Secondary Outcome Measures

Name	Time	Method
o secondary outcome measures